TheStreet.comGW Pharmaceuticals Is Set to Benefit as Cannabis Takes on CancerTheStreet.comThe U.S. Department of Agriculture is expected to grant approval in the first half this year, with the European Union regulatory body following suit in the second half. And the stock, which is already up more than 15.3% this year, will likely skyrocket …and more »

Read More: GW Pharmaceuticals Is Set to Benefit as Cannabis Takes on Cancer – TheStreet.com

Comments are closed, but trackbacks and pingbacks are open.